Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Abbott

Medtronic sees 23 serious medical device recalls in two years

Medtronic, battered by a high number of serious medical device recalls in recent years, says it is toughening its internal assessments for acquiring new products.

Tribune News Service

Abbott to Exit Mainland Chinese Baby Formula Market by 2023

American health-care giant cites shrinking market share amid stiff competition but will expand other businesses including diagnostics, devices and pharmaceuticals

Caixin Global

Revealed: group shaping US nutrition receives millions from big food industry

Academy of Nutrition and Dietetics has a record of quid pro quos with a range of food giants, documents show

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Bill of the Month: $38,398 for a single shot of a very old cancer drug

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn’t been going out long when she laid down the law: He had to get a physical.

Tribune News Service

For Highland Park man, why did a single shot of a very old cancer drug cost $38,398?

What’s behind the $38,398 price tag for a single dose of the drug to treat prostate cancer? A mixture of unrelenting drug price increases and hospital system consolidation.

Chicago Sun-Times

It cost $38,398 for a single shot of a very old cancer drug

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?

WEKU

Market Rallies, Hits Resistance As Treasury Yields Soar; Tesla, Netflix Are Big Movers: Weekly Review

Stocks jumped Monday, but soon hit resistance amid surging Treasury yields. Tesla hit lows on earnings while Netflix jumped.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Abbott plans a new $500M baby-formula plant to increase U.S. capacity for the vital product

Abbott Laboratories is building a new infant-formula manufacturing plant after the product shortage of the past year revealed gaps in U.S. production capacity.

Tribune News Service

Why A Quarterly Beat, Guidance Boost Didn't Stoke Abbott Laboratories Stock

Abbott enjoyed a third-quarter beat thanks, in part, to its Covid tests. But those sales are expected to peter out, and ABT stock slumped.

Investors Business Daily

Similac baby formula products recalled

The recall, issued on Oct. 14, includes the brands Similac and Pedialyte Electrolyte Solution

Salon

Special Olympics athlete Josh Holley is one step closer to conquering Abbott World Marathon Majors

Holley’s mission is to bring awareness to all disabilities with the message, “Our Ability is STRONGER than our dis-Ability.”

Chicago Sun-Times

Abbott recalls select baby formula over spoilage concerns

Select Similac products are part of a new recall from Abbott Nutrition.

Axios

Baby formula disaster failed to dent Abbott Labs’ ESG score

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

Tribune News Service

Sheryl Lee Ralph on Abbott Elementary, being ‘black famous’ and scolding Kimmel

The 65-year-old mega-talent has been criminally underappreciated until now – ‘Isn’t it such a blessing that I could remain relevant after all of these years?’

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Here's what the FDA says contributed to the baby formula shortage crisis

The Food and Drug Administration rattled off 15 reasons behind the national baby formula shortage, but couldn't identify a specific person or agency responsible.

The Independent UK

FDA concedes delays in response to baby formula shortage

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory

Tribune News Service

Neal Justin: 'Abbott Elementary' is back in session

"The White Lotus" may have taken the most Emmys this year but "Abbott Elementary" star Sheryl Lee Ralph went home with our hearts.

WEKU

Who is Emmy winner Quinta Brunson ... besides the woman who had to step over Kimmel?

Brunson had already made history when she was nominated for three Emmys for Abbott Elementary

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Ken Paxton again tries to intervene in suit with Dallas hospital over transgender care

DALLAS — Texas Attorney General Ken Paxton is attempting for the second time to intervene in a legal fight over gender-affirming medical care at two Dallas hospitals.

Chicago Sun-Times

Latest recalls of formula meant frantic search for family of suburban boy, 5, who needs it to survive

With help from La Rabida Children’s Hospital, Zayne Negoski of Joliet got an alternative tube-feeding formula. But his family and those of other medically needy kids have struggled and often had to pay more after Aug. 10 recall.

The Philadelphia Inquirer

PHILADELPHIA — The world is about to see a whole lot more from Abbott Elementary star and creator Quinta Brunson.

StockNews.com

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

Chicago Tribune

Abbott reports strong earnings despite infant formula crisis

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to criticism over problems that led to the shutdown of one of its infant formula-producing plants.

Investors Business Daily

Abbott Posts Beastly Covid Testing Growth — But It's Not Sustainable

Abbott Laboratories can credit its Covid testing efforts for its second-quarter beat, an analyst said Wednesday. But ABT stock toppled.

StockNews.com

2 Medical Stocks That Are Attractive Buys Right Now

Amid an inflationary environment, the medical sector is poised to stay afloat given the inelastic demand for medical products and services, impressive breakthroughs, and the rising need to serve an aging population. Therefore, fundamentally sound medical stocks Abbott Laboratories (ABT) and Utah Medical Products (UTMD) could be solid investments right…

1 … 5 6 7 8

People

Tyler Pasciak LaRiviere

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.